Overview

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

Status:
RECRUITING
Trial end date:
2028-04-30
Target enrollment:
Participant gender:
Summary
To learn if cemiplimab can help to control dMMR colon cancer.
Phase:
PHASE2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Regeneron Pharmaceuticals
Treatments:
cemiplimab